Through epidemiologic studies, high levels of IGFBP3 are associated with decreased risk of several common cancers, including PCa [78], breast cancer [79], colorectal cancer [80] and lung cancer [81]. This evidence concerns the gene IGFBP3 and posterior cortical atrophy.